Pharmacokinetics/Metabolism and Tissue Distribution
CBT offers drug metabolism and pharmacokinetic (DMPK) studies in support of drug candidate selection or regulatory submission. Based on goals our skilled in vitro and in vivo ADME scientists, together with our pharmacokineticists have the ability to design and interpret both in vitro and in vivo components of your drug metabolism studies. The PK parameters assessed include AUC, half-life, volume of distribution, bioavailability, AUC, Cmax, Tmax, first order rate constant for absorption, terminal elimination rate constant; clearance, volume of distribution, and bioavailability. We have experience with a number of dose routes, including intravenous (IV), oral (PO), transdermal, intra-peritoneal (IP), intra-muscular (IM), subcutaneous (SC) etc, depending on the specific design and objective of the study.
Following studies are offered
Custom-designed ADME studies in multiple species of laboratory animals
Drug kinetics in plasma
Quantitative tissue distribution of drug
Metabolic profiling of drug using animal and human microsomes, S9 and hepatocytes